Kapitalradar

Swiss capital increases, read from the official gazette and scored for financing rounds.

updated every weekdayrelease r10data as of 8 Oct 2026

↺ Try a rewind: Soverli AG on 24 Sep 2025, 83 days before the round was announced
Latest available record · 8 Oct 2026

Release evaluation · 7 Oct 2026 · does not rewind · rules + Claude: precision 2%–100% (n=17), recall 16/30 announced rounds · rules-only: precision 1%–99% (n=29), recall 18/30 announced rounds · Methodology

← Back to the feed

SuisHealth Biotech AG

History from 22 Feb 2018

UID
CHE-471.295.070
Legal form
AG
Canton
ZH
Founded
22 Feb 2018
Amount raised
not in the SHAB
Lead investor
not in the SHAB
Nominal capital · CHFCHF 286k
71k143k214k286k17 Oct 2025 · CHF 286k
  • shares

Record

  1. SHAB published 11 Nov 2024 · legal date 31 Oct 2024

    Name changed

    Titlis Financial Services AG → SuisHealth Biotech AG

    SHAB HR02-1006174757 ↗

  2. SHAB published 17 Oct 2025 · legal date 19 Sep 2025

    Capital increase

    Likely financing

    Paid in cash

    Nominal capital
    200’000 → 285’715
    Shares
    200’000 → 285’715
    New shares, % of post-step shares
    30.0% (85’715 new)

    Aktienkapital neu: CHF 285'715.00 [bisher: CHF 200'000.00]. Liberierung Aktienkapital neu: CHF 285'715.00 [bisher: CHF 200'000.00]. Aktien neu: 285'715 Namenaktien zu CHF 1.00 [bisher: 200'000 Namenaktien zu CHF 1.00].

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0

    Classifier score 0.60 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006460627 ↗

Published by 19 Oct 2025

Latest available record · 8 Oct 2026